BFC Planning’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
BFC Planning's WST Position: Q3 2026 in Review
BFC Planning increased its West Pharmaceutical (WST) stake by 18% in Q3 2026, buying an estimated $49.8K and bringing the position to 916 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #742.
BFC Planning first reported a position in WST in Q3 2024 and has held it in 9 quarters since. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- BFC Planning held 916 shares of West Pharmaceutical worth $339K as of Q3 2026.
- BFC Planning bought 141 West Pharmaceutical shares in Q3 2026, an estimated $49.8K.
- West Pharmaceutical made up 0.01% of BFC Planning's portfolio in Q3 2026, its #742 holding.
- BFC Planning first reported a position in West Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
- 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.